Showing results (461-470 of 632) with videos related to

Sort By:
Pageof 64
AIDS (London, England)|December 15, 2010
Boosted protease inhibitors and the electrocardiographic measures of QT and PR durationsElsayed Z Soliman, Jens D Lundgren, Mollie P Roediger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 12, 2008
Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA StudyWendy P Bannister, Alessandro Cozzi-Lepri, Bonaventura Clotet, et al.
Antiviral Therapy|March 27, 2009
Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA studyMatthijs van Luin, Wendy P Bannister, Amanda Mocroft, et al.
Journal of Electrocardiology|December 15, 2010
Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the Strategies for Management of Antiretroviral Therapy studyElsayed Z Soliman, Ronald J Prineas, Mollie P Roediger, et al.
AIDS (London, England)|June 20, 2015
HIV resistance testing and detected drug resistance in EuropeAnna Schultze, Andrew N Phillips, Roger Paredes, et al.
Open Forum Infectious Diseases|January 25, 2018
Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART StudyJose R Castillo-Mancilla, Andrew N Phillips, James D Neaton, et al.
AIDS (London, England)|June 3, 2009
Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapyAnouk M Kesselring, Ferdinand W Wit, Caroline A Sabin, et al.
AIDS (London, England)|February 9, 2016
Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?David C Boettiger, Caroline A Sabin, Andrew Grulich, et al.
Pageof 64